Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1201-1206

  Longatto Filho, Adhemar ^a   Costa, Sandra M ^a   Milanezi, Fernanda ^a,b   Montruccoli, Daniele ^c   Montruccoli, Gian Carlo ^d   Baltazar, Fátima ^a   Schmitt, Fernando C ^b,e  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Department of Obstetrics and Gynecology   (Italy)

^e University of Porto   (Portugal)

Author keywords

Angiothermography; Breast cancer; Breast disease; CD31; Dynamic angiothermography; Thermography; VEGF; VEGFR 1; VEGFR 2

Indexed keywords

CD31 ANTIGEN; LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ARTICLE; BREAST; BREAST TUMOR; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; HUMAN; METABOLISM; MICROCIRCULATION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; THERMOGRAPHY; VASCULARIZATION;

ANTIGENS, CD31; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIGANDS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; THERMOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 38449116944     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1201     Document Type: Article

References (20)

1. Cancer Facts and Figures. American Cancer Society, 2004.
2. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G and Slamon DJ: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17: 2639-2642, 1999.
3. Suzuki T, Toi M, Saji S, Horiguchi K, Aruga T, Suzuki E, Horiguchi S, Funata N, Karasawa K and Kamata N: Early breast cancer. Int J Clin Oncol 11: 108-119, 2006.
4. Linderholm B, Grankvist K, Wilking N, Johansson M, Tavelin B and Henriksson R: Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol 18: 1423-1431, 1998. (Pubitemid 30205387)
5. Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S and Hicklin DJ: The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int J Cancer 119: 1519-1529, 2006. (Pubitemid 44258756)
6. Dales JP, Garcia S, Bonnier P, Duffaud F, Carpentier S, Djemli A, Ramuz O, Andrac L, Lavaut M, Allasia C and Charpin C: Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma. Ann Pathol 23: 297-305, 2003. (Pubitemid 37279899)
7. Costa C, Soares R and Schmitt F: Angiogenesis: now and then. APMIS 112: 402-412, 2004. (Pubitemid 39642170)
8. Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C and Charpin C: Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. Int J Oncol 26: 977-984, 2005.
9. Weis SM and Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504, 2005. (Pubitemid 41613541)
10. Takahashi H and Shibuya M: The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci 109: 227-241, 2005. (Pubitemid 41337127)
11. Wright T and McGechan A: Breast cancer: new technologies for risk assessment and diagnosis. Mol Diagn 7: 49-55, 2003.
12. Ng EY and Sudharsan NM: Computer simulation in conjunction with medical thermography as an adjunct tool for early detection of breast cancer. BMC Cancer 28: 4-17, 2004.
13. Isard JH, Sweitzer CJ and Edelstien GR: Breast thermography: a prognostic indicator for breast cancer survival. Cancer 62: 484-488, 1988.
14. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 46: 467-473, 1986.
15. Montruccoli GC, Montruccoli DS and Casali F: Physicochemical characterization of a new plate for breast contact thermography. Physica Medica 20: 27-31, 2004.
16. Tavassoli FA and Deville P: Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours. IARC Press, WHO, Lyon, 2003.
17. Viacava P, Naccarato AG, Bocci G, Fanelli G, Aretini P, Lonobile A, Evangelista G, Montruccoli G and Bevilacqua G: Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol 204: 140-146, 2004. (Pubitemid 39335286)
18. Naccarato AG, Viacava P, Bocci G, Fanelli G, Aretini P, Lonobile A, Montruccoli G and Bevilacqua G: Definition of the microvascular pattern of the normal human adult mammary gland. J Anat 203: 599-603, 2003. (Pubitemid 37509127)
19. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997. (Pubitemid 27076453)
20. Marinho A, Soares R, Ferro J, Lacerda M and Schmitt FC: Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract 193: 267-273, 1997. (Pubitemid 27399700)